Bausch Health Companies Inc (BHC)
Official siteHEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NYSE
Market Cap: $3.13B
Last updated: Nov 17, 2026 at 11:05 AM ET
Bausch Health Companies Inc (BHC) Stock Forecast
Analysts expect Bausch Health Companies (BHC) to earn $4.91 per share in the fiscal year ending Dec 31, 2026, on revenue of $11.03B. Of 7 analysts, 0 rate the stock Buy or Strong Buy, 7 Hold and 0 Sell or Strong Sell, for a consensus of Hold. Over the last 30 days, 1 estimate for the fiscal year ending Dec 31, 2026 was revised up and 0 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 7 ratings average 3.00, inside the Hold band from 2.5 up to 3.5. All 7 rate it Hold.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 0 | 0.0% |
| Buy | 0 | 0.0% |
| Hold | 7 | 100.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Hold
- Total analysts
- 7
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus falls 11.6% and revenue estimates fall 0.6%.
- Fiscal year ending Dec 31, 2026
- $4.91
- EPS consensus, revenue $11.03B
- Fiscal year ending Dec 31, 2027
- $4.34
- EPS consensus, revenue $10.96B
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $4.91 | $4.32 to $5.33 | 6 | $11.03B | $10.92B to $11.11B | 5 |
| Dec 31, 2027 | $4.34 | $4.00 to $4.77 | 6 | $10.96B | $10.85B to $11.14B | 5 |
Quarterly Estimates
The EPS consensus falls from $1.39 for the quarter ending Dec 31, 2026 to $0.79 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $1.39 | $1.21 to $1.56 | 4 | $2.81B | $2.72B to $2.93B | 4 |
| Mar 31, 2027 | $0.79 | $0.71 to $0.87 | 4 | $2.52B | $2.50B to $2.54B | 2 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 3 upward and 1 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 1 | 0 |
| Fiscal year ending Dec 31, 2027 | 1 | 1 |
| Quarter ending Mar 31, 2027 | 1 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has risen 9.8% from $4.47.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $4.91 | $4.79 | $4.47 | $4.47 | $4.47 | +9.8% |
| Fiscal year ending Dec 31, 2027 | $4.34 | $4.31 | $4.19 | $4.19 | $4.19 | +3.5% |
| Quarter ending Mar 31, 2027 | $0.79 | $0.82 | $0.82 | $0.82 | $0.82 | -3.0% |
Frequently Asked Questions About BHC
What is the BHC stock forecast?
Consensus analyst estimates put Bausch Health Companies's EPS at $4.91 for the fiscal year ending Dec 31, 2026, on revenue of $11.03B. The consensus rating from 7 analysts is Hold.
How do analysts rate BHC stock?
Of 7 analysts covering Bausch Health Companies, 0 rate it Strong Buy, 0 Buy, 7 Hold, 0 Sell and 0 Strong Sell, for a consensus of Hold.
What EPS do analysts expect from BHC next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $4.91, with estimates from $4.32 to $5.33 from 6 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $4.34, with estimates from $4.00 to $4.77 from 6 analysts.
What revenue do analysts expect from Bausch Health Companies next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $11.03B, with estimates from $10.92B to $11.11B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $10.96B, with estimates from $10.85B to $11.14B.
How many analysts cover BHC?
7 analysts rate Bausch Health Companies stock, and 6 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
BHC pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors